trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Comorbid anxiety and major depressive disorder are more persistent and treatment-resistant than pure forms of major depressive disorder and anxiety disorders.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Comorbid anxiety and major depressive disorder are more persistent and treatment-resistant than pure forms of major depressive disorder and anxiety disorders?

Yes. Multiple clinical studies and reviews support the conclusion that comorbid anxiety and major depressive disorder are more persistent, disabling, and treatment-resistant than pure forms of either disorder alone.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the claim that the comorbidity of anxiety disorders and major depressive disorder is associated with poorer treatment response and higher rates of treatment resistance compared to pure depression.

Evidence for · 3
RESTING-STATE FUNCTIONAL CONNECTIVITY CORRELATES OF ANXIETY CO-MORBIDITY IN MAJOR DEPRESSIVE DISORDER.
2022
The systematic review notes that major depressive disorder comorbid with anxiety exhibits poorer functional outcomes and greater resistance to first-line treatments.
Get citation
Briley, P. M., Webster, L., Boutry, C., Cottam, W. J., Auer, D. P., Liddle, P., & Morriss, R. (2022). RESTING-STATE FUNCTIONAL CONNECTIVITY CORRELATES OF ANXIETY CO-MORBIDITY IN MAJOR DEPRESSIVE DISORDER.. doi.org. https://doi.org/10.1016/j.neubiorev.2022.104701

See more details
More for · 2
Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study.
2024
A nationwide study found that anxiety disorders are significantly associated with treatment-resistant depression (odds ratio 1.88).
Get citation
Chen, L., Chen, M., Bai, Y., Chen, T., & Su, T. (2024). Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study.. doi.org. https://doi.org/10.1097/YIC.0000000000000574

Factors associated with pharmaco resistance in major depressive disorder.
2025
Clinical research indicates a significant association between treatment-resistant depression and psychiatric comorbidities, particularly anxiety disorders.
Get citation
Othman, S. B., Mami, H., Krir, M. W., Ghorbel, O., Abdelghaffar, W., & Oumaya, A. (2025). Factors associated with pharmaco resistance in major depressive disorder.. doi.org. https://doi.org/10.62438/tunismed.v103i12.6274

What does the evidence say?

The retrieved literature consistently supports the claim that the comorbidity of anxiety disorders and major depressive disorder is associated with poorer treatment response and higher rates of treatment resistance compared to pure depression.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work